ICU Medical, Inc. (ICUI)
179.27
+1.97
(+1.11%)
USD |
NASDAQ |
Nov 13, 16:00
178.78
-0.49
(-0.27%)
After-Hours: 19:59
ICU Medical Enterprise Value : 5.389B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 5.389B |
| November 12, 2026 | 5.340B |
| November 11, 2026 | 5.364B |
| November 10, 2026 | 5.460B |
| November 09, 2026 | 5.378B |
| November 06, 2026 | 5.210B |
| November 05, 2026 | 5.098B |
| November 04, 2026 | 5.223B |
| November 03, 2026 | 4.953B |
| November 02, 2026 | 4.967B |
| October 30, 2026 | 5.002B |
| October 29, 2026 | 5.123B |
| October 28, 2026 | 5.067B |
| October 27, 2026 | 4.987B |
| October 26, 2026 | 5.056B |
| October 23, 2026 | 5.073B |
| October 22, 2026 | 5.115B |
| October 21, 2026 | 4.928B |
| October 20, 2026 | 4.934B |
| October 19, 2026 | 4.938B |
| October 16, 2026 | 4.982B |
| October 15, 2026 | 5.088B |
| October 14, 2026 | 4.974B |
| October 13, 2026 | 4.988B |
| October 12, 2026 | 5.005B |
| Date | Value |
|---|---|
| October 09, 2026 | 4.915B |
| October 08, 2026 | 4.836B |
| October 07, 2026 | 4.808B |
| October 06, 2026 | 4.900B |
| October 05, 2026 | 4.942B |
| October 02, 2026 | 4.891B |
| October 01, 2026 | 4.836B |
| September 30, 2026 | 4.920B |
| September 29, 2026 | 5.076B |
| September 28, 2026 | 5.091B |
| September 25, 2026 | 5.114B |
| September 24, 2026 | 5.141B |
| September 23, 2026 | 5.073B |
| September 22, 2026 | 5.014B |
| September 21, 2026 | 4.870B |
| September 18, 2026 | 4.806B |
| September 17, 2026 | 4.813B |
| September 16, 2026 | 4.880B |
| September 15, 2026 | 4.887B |
| September 14, 2026 | 4.930B |
| September 11, 2026 | 4.902B |
| September 10, 2026 | 4.921B |
| September 09, 2026 | 5.015B |
| September 08, 2026 | 5.012B |
| September 04, 2026 | 5.180B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Baxter International, Inc. | 19.36B |
| Haemonetics Corp. | 6.460B |
| Merit Medical Systems, Inc. | 5.505B |
| Teleflex, Inc. | 7.519B |
| Globus Medical, Inc. | 9.161B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 26.85M |
| Revenue (Quarterly) | 561.59M |
| Total Expenses (Quarterly) | 534.74M |
| EPS Diluted (Quarterly) | 1.068 |
| Gross Profit Margin (Quarterly) | 36.11% |
| Profit Margin (Quarterly) | 4.78% |
| Earnings Yield | 1.33% |
| Operating Earnings Yield | 3.92% |
| Normalized Earnings Yield | 2.390 |